Table 3.
Unadjusted associations between individual characteristics [n (%)] of children 6 months to <5 years (n = 263) or 5 to <18 years (n = 120), hospitalized with community-acquired pneumonia and length of stay (LOS) or intensive care unit (ICU) admission
| LOS | ICU admission | ||||||
|---|---|---|---|---|---|---|---|
| <4 days | ≥ 4 days | No | Yes | ||||
| Characteristic | N (%) | (%) | (%) | P value | (%) | (%) | P value |
| Age 6 months to <5 years | |||||||
| Demographic | |||||||
| Race/Ethnicity | 0.35 | 0.64 | |||||
| White | 28 (10.6) | 10.6 | 10.9 | 10.1 | 15.4 | ||
| Black | 210 (79.8) | 81.4 | 75.0 | 80.6 | 73.1 | ||
| Other | 25 (9.5) | 8.0 | 14.1 | 9.3 | 11.5 | ||
| Gender | 0.87 | 0.67 | |||||
| Female | 121 (46.0) | 45.7 | 46.9 | 45.6 | 50.0 | ||
| Male | 124 (54.0) | 54.3 | 53.1 | 54.4 | 50.0 | ||
| Fall/winter season | 157 (59.7) | 59.3 | 60.9 | 0.82 | 60.7 | 50.0 | 0.29 |
| Environmental tobacco smoke exposure | 27 (10.4) | 11.8 | 6.3 | 0.21 | 9.9 | 15.4 | 0.32 |
| Medical History | |||||||
| Asthma/reactive airway disease | 126 (47.9) | 44.7 | 57.8 | 0.07 | 46.8 | 57.7 | 0.29 |
| Chronic conditions other than asthma | 63 (24.0) | 22.1 | 29.7 | 0.22 | 23.6 | 26.9 | 0.71 |
| Prior antibiotics | 59 (22.4) | 22.6 | 21.9 | 0.90 | 22.4 | 23.1 | 0.93 |
| Pneumococcal vaccinea | 256 (98.5) | 98.5 | 98.4 | 0.97 | 98.7 | 96.0 | 0.29 |
| Respiratory virus positive | |||||||
| RSV | 110 (41.8) | 42.7 | 39.1 | 0.61 | 43.9 | 23.1 | 0.04 |
| Rhinovirus | 89 (33.8) | 36.2 | 26.6 | 0.16 | 35.4 | 19.2 | 0.10 |
| Age 5 to <18 years | |||||||
| Demographic | |||||||
| Race/Ethnicity | 0.81 | 0.73 | |||||
| White | 19 (15.8) | 16.5 | 14.6 | 16.7 | 12.5 | ||
| Black | 93 (77.5) | 76.0 | 80.5 | 76.0 | 83.3 | ||
| Other | 8 (6.7) | 7.6 | 4.9 | 7.3 | 4.2 | ||
| Gender | 0.05 | 0.16 | |||||
| Female | 50 (41.7) | 35.4 | 53.7 | 38.5 | 54.2 | ||
| Male | 70 (58.3) | 64.6 | 46.3 | 61.5 | 45.8 | ||
| Fall/winter season | 68 (56.7) | 58.2 | 53.7 | 57.3 | 54.2 | 0.78 | |
| Environmental tobacco smoke exposure | 17 (14.2) | 15.2 | 12.2 | 0.66 | 14.6 | 12.5 | 1.00 |
| Medical History | |||||||
| Asthma/reactive airway disease | 77 (64.2) | 73.4 | 46.3 | 0.003 | 64.6 | 62.5 | 0.85 |
| Chronic conditions other than asthma | 29 (24.2) | 19.0 | 34.2 | 0.07 | 20.8 | 37.5 | 0.09 |
| Prior antibiotics | 23 (19.2) | 16.5 | 24.4 | 0.30 | 19.8 | 16.7 | 0.73 |
| Pneumococcal vaccineb | 91 (76.5) | 83.5 | 62.5 | 0.01 | 80.2 | 60.9 | 0.05 |
| Respiratory virus positive | |||||||
| RSV | 13 (10.8) | 12.7 | 7.3 | 0.37 | 9.4 | 16.7 | 0.30 |
| Rhinovirus | 59 (49.2) | 55.7 | 36.6 | 0.05 | 46.9 | 58.3 | 0.32 |
aReceipt of at least one or more doses prior to enrollment, missing data for 3 subjects. Bold indicates a significant P value of <0.05
bReceipt of at least one or more doses prior to enrollment, missing data for 1 subject